Trial NCT01130701

View at ClinicalTrials.gov 
Org. Study IDs: UM2010-01

Last trial update was posted on 2015-03-17

MeSH Interventions

Capecitabine Panitumumab

MeSH Conditions

Pancreatic Neoplasms

Other Conditions

Pancreatic Cancer

Stopping Reasons

Study never went beyond FDA application for an IND #. FDAA required institutional DSMC which this institution then lacked.

Limitations And Caveats

N/A

Result Publications


Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID